Research Centers of Excellence

Clinical Trials

Research Funding

Research Advance: DLB Genetics Uniquely Different from Parkinson’s

The human genome is a complete set of a person’s DNA. Serving as a blueprint for all cells in the body, the genome contains about 20,000 genes. The first human […]
Read More

LBD: State of the Science

We are entering an era of unprecedented opportunity for understanding and treating Lewy body dementia (LBD). Our newest white paper, Lewy Body Dementia: The State of the Science provides the […]
Read More

LBD is the Most Expensive Dementia in America

Dementia is one of the most expensive diseases in the United States, increasing healthcare costs 3 times over those without dementia. Until now, studies on the costs of different dementia […]
Read More

Adult Day Service Boosts Beneficial Stress Hormone in Caregivers

A new study reveals family caregivers have an increase in the beneficial stress hormone DHEA-S on days when they use an adult day service for their relatives with dementia. DHEA-S […]
Read More

LBD Duration Shortens with Co-existing Alzheimer’s Disease

The rate of progression in Lewy body dementia (LBD) is hard to predict at the time of diagnosis. New research indicates the presence of a second neurodegenerative disease process, Alzheimer’s […]
Read More

LBD Diagnostic Symptoms Checklist

Because Lewy body dementia is the most misdiagnosed form of dementia, LBDA developed a useful checklist to help physicians and their patients identify key LBD symptoms used to make a […]
Read More

New Diagnostic Criteria Published for DLB

If you talk with families, many will share that getting a diagnosis for one specific form of LBD, called dementia with Lewy bodies (DLB), was a challenge.  Sometimes the diagnosis […]
Read More

Daytime Sleepiness is More Common in Dementia with Lewy Bodies than Alzheimer’s

Drowsiness and daytime sleepiness (despite getting adequate sleep the night before) are often described by individuals with dementia with Lewy bodies (DLB) and their caregivers. This is reported even in […]
Read More

Treatment Study Halted Early Because of Promising Results

With all the recent news about failed clinical trials for disease-modifying treatments for Alzheimer’s disease, a little encouraging news is timely. ACADIA Pharmaceuticals announced an early end to one of […]
Read More

Early Visual Hallucinations Greatly Increase Odds of LBD Over Alzheimer’s

Visual hallucinations are a core feature of dementia with Lewy bodies, occurring in 32 to 85 percent of autopsy-confirmed cases. Individuals with Alzheimer’s disease also experience hallucinations, though to a […]
Read More